SWK Holdings Corporation: Business Overview, Financials & Competitive Analysis
SWK Holdings Corporation scores 6/10 on the AskCyborg Cyborg Score (Solid). Niche specialty finance player with strong recent earnings growth and improving portfolio dynamics, though facing headwinds from venture capital market contraction. Revenue declined 19% year-over-year to $27.55 million in 2024, reflecting challenging market conditions in venture financing. However, Q2 2025 adjusted non-GAAP net income for the finance receivables segment.
What is SWK Holdings Corporation's industry? SWK Holdings Corporation (swkhold.com) operates in Specialty Finance / Healthcare Capital / Venture Debt. AskCyborg classifies SWK Holdings Corporation under Specialty Finance / Healthcare Capital / Venture Debt in its company registry.
SWK Holdings is a life science-focused specialty finance company that provides non-dilutive financing to small- and mid-sized commercial-stage healthcare companies to fuel development and commercialization of medical ...
Cyborg Score thesis
Niche specialty finance player with strong recent earnings growth and improving portfolio dynamics, though facing headwinds from...
Read the full analyst-debate transcript →Get the Latest SWK Holdings Corporation Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeSWK Holdings Corporation Overview
Pro stress-test →SWK Holdings is a life science-focused specialty finance company that provides non-dilutive financing to small- and mid-sized commercial-stage healthcare companies to fuel development and commercialization of medical technologies and products. The company operates through two primary segments: Finance Receivables (royalty and financing solutions) and Pharmaceutical Development (through its Enteris BioPharma subsidiary).
Strategic Profile
Pro stress-test →As a venture debt firm specializing in early-stage through growth-stage capital investments, SWK focuses on healthcare sectors including biopharma, medical devices, diagnostics, and life science tools, alongside technology and green energy/sustainability. SWK specializes in tailored capital solutions that preserve partners' ownership interests.
Competitive Landscape
Pro stress-test →SWK competes in the specialized finance sector focused on global healthcare, providing capital to a broad range of life science companies, institutions, and inventors. Key competitors include other healthcare-focused specialty finance and venture debt providers such as Silicon Valley Bank's healthcare lending division (now bridging SVBB assets), Horizon Technology Finance, and Heritage Insurance Holdings (healthcare-focused lending). SWK's niche focus on royalty financing and non-dilutive solutions differentiates it from traditional venture capital.
Industry Context
SWK Holdings Corporation operates in Specialty Finance / Healthcare Capital / Venture Debt.
Key facts
Founded: 1996 · Headquarters: Dallas, Texas · Revenue: $27.55M (2024) · Market cap: $208M